These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34154795)

  • 61. Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement.
    So RJ; Hidalgo Lopez JC; Ballestas SA; Klein AM; Steuer C; Shin DM; Abousaud M; Teng Y; Saba NF; Tkaczuk AT; Schaefer ES; Seiwert TY; McClellan K; Best SR
    Laryngoscope; 2024 Feb; 134(2):577-581. PubMed ID: 37470254
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis.
    Wemer RD; Lee JH; Hoffman HT; Robinson RA; Smith RJ
    Ann Otol Rhinol Laryngol; 2005 Nov; 114(11):836-9. PubMed ID: 16358603
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of cidofovir and the measles, mumps, and rubella vaccine in the treatment of recurrent respiratory papillomatosis.
    Meacham RK; Thompson JW
    Ear Nose Throat J; 2017 Feb; 96(2):69-74. PubMed ID: 28231366
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of vocal fold injection of cidofovir and bevacizumab in a porcine model.
    Connor MP; Brown A; Palazzolo M; Kunkel J; Eller R; Hartnick C; Maturo S
    JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):155-9. PubMed ID: 24288019
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intralesional cidofovir in severe juvenile respiratory papillomatosis.
    Ablanedo-Terrazas Y; Soda-Merhy A; Hernández-Palestina M; Ormsby CE; Reyes-Terán G
    B-ENT; 2012; 8(3):197-202. PubMed ID: 23113383
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Office-Based vs Traditional Operating Room Management of Recurrent Respiratory Papillomatosis: Impact of Patient Characteristics and Disease Severity.
    Tatar EÇ; Kupfer RA; Barry JY; Allen CT; Merati AL
    JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):55-59. PubMed ID: 27658005
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey.
    Best SR; Mohr M; Zur KB
    Laryngoscope; 2017 Oct; 127(10):2225-2229. PubMed ID: 28657692
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Systematic Review.
    Drejet S; Halum S; Brigger M; Skopelja E; Parker NP
    Otolaryngol Head Neck Surg; 2017 Mar; 156(3):435-441. PubMed ID: 28072562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
    Mikolajczak S; Quante G; Weissenborn S; Wafaisade A; Wieland U; Lüers JC; Klussmann JP; Beutner D
    Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2543-8. PubMed ID: 22766836
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review.
    Pogoda L; Ziylan F; Smeeing DPJ; Dikkers FG; Rinkel RNPM
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4229-4240. PubMed ID: 35462578
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population.
    Tkaczuk A; Trivedi S; Mody MD; Steuer CE; Shin DM; Klein AM; Saba NF
    Laryngoscope; 2021 Mar; 131(3):E921-E928. PubMed ID: 33107615
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antiviral agents for the treatment of recurrent respiratory papillomatosis: a systematic review of the English-language literature.
    Chadha NK; James AL
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):863-9. PubMed ID: 17547971
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
    Donne AJ; Rothera MP; Homer JJ
    Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cidofovir modulated gene expression in recurrent respiratory papillomatosis.
    Poetker DM; Patel NJ; Kerschner JE
    Int J Pediatr Otorhinolaryngol; 2008 Sep; 72(9):1385-92. PubMed ID: 18620760
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bevacizumab chemotherapy for management of pulmonary and laryngotracheal papillomatosis in a child.
    Zur KB; Fox E
    Laryngoscope; 2017 Jul; 127(7):1538-1542. PubMed ID: 27996119
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-Term Follow-Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis.
    Evers G; Schliemann C; Beule A; Schmidt LH; Schulze AB; Kessler C; Hoffmann TK; Wiewrodt R; Groll AH; Bleckmann A; Rudack C; Berdel WE; Mohr M
    Laryngoscope; 2021 Jun; 131(6):E1926-E1933. PubMed ID: 33382105
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Renal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis.
    Robinson CH; Hart-Matyas M; Morgenstern DA; Noone D; Campisi P
    Ann Otol Rhinol Laryngol; 2024 Jan; 133(1):119-123. PubMed ID: 37439024
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systemic and Intralesional Bevacizumab in Juvenile Onset Recurrent Respiratory Papillomatosis: A Report of Two Cases.
    Goyal A; Kapoor D; Saha R
    Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):5098-5101. PubMed ID: 34426784
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir.
    El Hakim H; Waddell AN; Crysdale WS
    J Otolaryngol; 2002 Dec; 31(6):333-5. PubMed ID: 12593542
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Photoangiolytic laser treatment of recurrent respiratory papillomatosis: a scaled assessment.
    Kuet ML; Pitman MJ
    J Voice; 2013 Jan; 27(1):124-8. PubMed ID: 23102824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.